Role of MED12 in transcription and human behavior

Pharmacogenomics

Volumn 8, Issue 8, 2007, Pages 909-916

  Philibert, Robert A ^a   Madan, Anup ^b  

^a UNIVERSITY OF IOWA   (United States)

^b INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

Author keywords

MED12; Mental retardation; Psychosis; Schizophrenia; X chromosome

Indexed keywords

CELL NUCLEUS RECEPTOR; MEDIATOR OF RNA POLYMERASE II TRANSCRIPTION 12 PROTEIN; PROTEIN MED12; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX10; TRANSCRIPTION FACTOR SOX8; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG; WNT PROTEIN;

AMINO ACID SEQUENCE; BEHAVIOR DISORDER; CARBOXY TERMINAL SEQUENCE; DISEASE SEVERITY; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MISSENSE MUTATION; NERVE CELL DIFFERENTIATION; NONHUMAN; OPITZ SYNDROME; PHARMACOGENOMICS; PROMOTER REGION; PROTEIN MOTIF; PSYCHOSIS; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; X CHROMOSOME; X LINKED MENTAL RETARDATION;

ANIMALS; GENE EXPRESSION REGULATION; GENETICS, BEHAVIORAL; HUMANS; RECEPTORS, THYROID HORMONE; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; VARIATION (GENETICS);

EUKARYOTA;

EID: 34548720441     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/14622416.8.8.909     Document Type: Review

References (49)

1. Levine M, Tjian R: Transcription regulation and animal diversity. Nature 424(6945), 147-151 (2003).
2. Rachez C, Freedman LP: Mediator complexes and transcription. Curr. Opin. Cell Biol. 13(3), 274-280 (2001).
3. Naar AM, Beaurang PA, Zhou S et al.: Composite co-activator ARC mediates chromatin-directed transcriptional activation. Nature 398(6730), 828-832 (1999).
4. Rachez C, Lemon BD, Suldan Z et al.: Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398(6730), 824-828 (1999).
5. Ito M, Roeder RG: The TRAP/SMCC/Mediator complex and thyroid hormone receptor function. Trends Endocrinol. Metab. 12(3), 127-134 (2001).
6. Kim S, Xu X, Hecht A, Boyer TG: Mediator is a transducer of Wnt/ β-catenin signaling. J. Biol. Chem. 281(20), 14066-14075 (2006).
7. Belakavadi M, Fondell ID: Role of the Mediator complex in nuclear hormone receptor signaling. Rev. Physiol. Biochem. Pharmacol. 156, 23-43 (2006).
8. Moghal N, Stemberg PW: A component of the transcriptional Mediator complex inhibits RAS-dependent vulval fate specification in C. elegans. Development 130(1), 57-69 (2003).
9. Guglielmi B, van Berkum NL, Klapholz B et al.: A high resolution protein interaction map of the yeast Mediator complex. Nucl. Acid Res. 32 (18). 5379-5391 (2004).
10. Ito M, Yuan CX, Okano HJ, Darnell RB, Roeder RG: Involvement of the TRAP220 component ofthe TRAP/SMCC coactivator complex in embryonic development and thyroid hormone action. Mol. Cell 5 (4), 683-693 (2000).
11. Zhu X, When M, Sinha I et al.: Genome-wide occupancy profile of mediator and the Srb8-11 module reveals interactions with coding regions. Mol. Cell. 22(2), 169-178 (2006).
12. Loncle N, Boube M, Joulia L et al.: Distinct roles for mediator Cdk8 module subunits in Drosophila development. EMBO J. 26(4), 1045-1054 (2007).
13. Elmlund H, Baraznenok V, Lindahl M et al.: The cyclin-dependent kinase 8 module sterically blocks mediator interactions with RNA polymerase II. Proc. Natl. Acad. Sci. USA 103(43), 15788-15793 (2006).
14. Trelsman J: Drosophilia homologues of the transcriptional coactivation complex subunits TRAP240 and TRAP230 are required for identical processes in eye-antennal disc development. Development 128(4 Suppl.), 603-615 (2001).
15. Yoda A, Koulke H, Okano H, Sawa H: Components of the transcriptional Mediator complex are required for asymmetric cell division in C. elegans. Development 132(8), 1885-1893 (2005).
16. Samuelsen CO, Baraznenok V, Khorosjutina O et al.: TRAP230/ARC240 and TRAP240/ARC250 mediator subunits are functionally conserved through evolution. Proc. Natl. Acad. Sci. USA 100(11), 6422-6427 (2003).
17. Riedl T, Egly JM: Phosphorylation in transcription: the CTD and more. Gene Expr. 9(1-2), 3-13 (2000).
18. van de Peppel J, Kettelarij N, van Bakel H et al.: Mediator expression profiling epistasis reveals a signal transduction pathway with antagonistic submodules and highly specific downstream targets. Mol. Cell 19(4), 511-522 (2005).
19. Kitano T, Schwarz C, Nickel B. Paabo S: Gene diversity patterns at 10 X-chromosomal loci in humans and chimpanzees. Mol. Biol. Evol. 20(8), 1281-1289 (2003).
20. Philibert RA, King BH, Winfield S et al.: Association of an X-chromosome dodecamer insertional variant allele with mental retardation. Mol. Psychiatry 3 (4), 303-309 (1998); Erratum: 4(2), 197 (1999).
21. Hong S-K, Haldin CE, Lawson ND et al.: The zebraftsh kohtalo/ trap230 gAne is requhrd for the development of the brain, neural crest, and pronephric kidney. Proc. Natl. Acad. Sci. USA 102(51), 18473-18478. (2005).
22. Philibert RA, Wififield SL, Damschrode-Williams P et al.: The genomic structure and developmental expression patterns of the human OPA-containing gene (HOPA). Hum. Genet. 105(1-2), 174-178 (1999).
23. Puck JM, Deschenes SM, Porter JC et al.: The interleukin-2 receptor γ chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1. Hum. Mol. Genet. 2(8), 1099-1104 (1993).
24. Tatebizadeh Z, Lam DY, Theodoro MF et al.: Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism. J. Med Genet. 43(5), E21 (2006).
25. Jamain S, Quach H, Betancur C et al.: Mutations of the X-linked genes encoding neuroiigins NLGN3 and NLGN4 am associated with autism. Nat. Genet. 34(1), 27-29 (2003).
26. Philibert RA, Winfield SL, Sandhu HK, Martin BM, Ginns EI: The structure and expression of the human neuroligin-3 gene. Gene 246(1-2), 303-310 (2000).
27. Ince, TA, Scotto KW. A conserved downstream element defines a new class of RNA polymerase 11 promoters. J. Biol. Chem. 270(51), 30249-30252 (1995).
28. Beyer KS, Klauck SM, Benner A, Poustka F, Poustka A: Association studies of the HOPA dodecamer duplication variant in different subtypes of autism. Am. J. Med. Genet. 114(1), 110-115 (2002).
29. Wharton KA, Yedvobnick B. Finnerty VG, Artavanis-Tsakonas S: OPA: a novel family of transcribed repeats shared by the Notch locus and other developmentally regulated loci in D. melanogaster. Cell, 40(1), 55-62 (1985).
30. +2, pathways. Oncogene 18(55), 7860-7872(1999).
31. Zhang H, Emmons SW: A C. elegans mediator protein confers regulatory selectivity on lineage-specific expression of a transcription factor gene. Genes Dev. 14 (17), 2161-2172 (2000).
32. Fischer B, Marinov M, Arcarc, A: Targeting irceptor tyrosine kinase signalling in small cell, king cancer (SCLC): what have we learned so far? Cancer Treat. Rev. 33(4), 391-406 (2007).
33. Zhou R, Bonneaud N, Yuan CX et al.: SOX9 interacts with a component of the 'human thyroid hormone receptor-associated protein complex. Nucleic Acids Res. 30(14), 3245-3252(2002).
34. Wang X, Yang N, Uno E, Roeder RG, Guo S: A subunit of the Mediator complex regulates vertebrate neuronal development. Proc. Natl. Acad. Sci. USA 103(46), 17284-17289 (2006).
35. Rau MJ, Fischer S, Neumann CJ: Zebrafish Trap230/Med,12 is required as a coactivator for Soxg-dependent neural crest, cartilage and ear development. Dev. Biol. 296(1), 83-93 (2006).
36. Janody F, Martirosyan Z, Beniali A, Treisman JE: Two subunits of the Drosophila Mediator complex act together to control cell affinity. Development 130 (16), 3691-3701 (2003).
37. Opitz JM, Kaveggia EG: Studies of malformation syndromes of man 33: the FG syndrome. An X-linked recessive syndrome of multiple congenital anomalies and mental retardation. Z. Kinderheilkd. 117(1), 1-18 (1974).
38. Risheg H, Graham JM, Clark RD et al.: A recurrent mutation in MED12 leading to R961W causes Opitz-Kaveggia syndrome. Nat. Genet. 39, 451-453 (2007).
39. Schwartz CE, Tarpey PS, Lubs HA et al.: The original Lujan syndrome family has a novel missense mutation (p.N1007S) in the MED12 gene. J. Med. Genet. 44, 472-477 (2007).
40. Philibert RA: A meta-analysis of the association of the HOPA12bp polymorphism and schizophrenia. Psychiatr Genet. 16(2), 73-76 (2006).
41. Phibert R, Bohle P, Secrest D et al.: The association of the HOPA 12bp polymorphism with schizophrenia in the NIMH genetics initiative for schizophrenia sample. Am. J. Med. Genet. (2007) (Epub ahead of print).
42. Spinks R, Sanclhu HK, Andreasen NC, Philibert RA: Association of the HOPA12bp allele with a large X-chromosome haplotype and positive symptom schizophrenia. Am. J. Med. Genet. 127B(1), 20-27 (2004).
43. DeLisi LE, Smith AB, Razi K et al.: Investigation of a candidate gene for schizophrenia on Xq13 previously associated with mental retardation and hypothyroidism. Am. J Med. Genet. 96(3), 398-403 (2000).
44. Carlsson A, Carlsson ML: A dopaminergic deficit hypothesis of schizophrenia: the path to discovery. Dialoguess Clin. Neurosci. 8(1), 137-142 (2006).
45. Castelo-Branco G, Arenas E: Function of Wnts in dopaminergic neuron development. Neurodegener. Dis. 3(1-2), 5-11 (2006).
46. Hung CC, Yeh JI, FanWJS, Chen CH: No association of a dodecamer duplication in the human opposite paired (HOPA) gene with mental retardation and schizophrenia in Chinese patients from Taiwan. Psychiatry Res. 119(1-2), 163-166 (2003).
47. Phillbert RA, Crowe R, Ryu G-Y et al.: Transcriptional profiling of lymphoblasts from subjects with panic disorder. Am. J. Med. Genet. (2007) (Epub ahead of print).
48. Philibert RA, Ryu G-Y, Yoon J-G et al.: Transcriptional profilling of subjects in the Iowa adoption studies. Am. J. Med. Genet. (2007) (Epub ahead of print).
49. Taatjes DJ, Naar AM, Andel F, 3rd, Nogales E, Tjian R: Structure, function, and activator-induced conformations of the CRSP coactivator. Science 295(5557), 1058-1062 (2002).